The above in vivo results revealed the protective efficiency of KDM3A knock-out against hyperglycemia-induced persistent myocardial injury and cardiac dysfunction might be associated with the inhibition of the expression and transcriptional activity of NF-κB/P65. Here, KDM3A is linked to Hyperglycemia.